Weedstocks Newswire Feed
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- At the request of IIROC, Eve & Co Incorporated (TSX-V:EVE) (the “Company” or “EVE”) wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.
ABOUT EVE & CO INCORPORATED
EVE, through its wholly owned subsidiary Natural MedCo Ltd., is a licensed producer and seller of dried cannabis and cannabis plants under the Access to Cannabis for Medical Purposes Regulations (the ACMPR). Natural MedCo Ltd. is Canada’s first female founded licensed producer, and received its cultivation license from Health Canada in 2016 and its sales license from Health Canada in June 2018.
EVE is led by a team of agricultural experts and has a 220,000 sq. ft. scalable greenhouse production facility located in Middlesex County, Ontario with 32 acres of adjacent land for future expansion. EVE has broken ground on an additional 780,000 sq. ft. expansion, bringing EVE’s total anticipated greenhouse capacity to 1,000,000 sq. ft.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Speakeasy Announces Change to Its Board of Directors and an Increase to Its Previously Announced Non-Brokered Private Placement
/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/
VANCOUVER, Sept. 10, 2018 /CNW/ - SpeakEasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the "Company" or "SpeakEasy") a late stage applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), is pleased to announce the appointment of Brian Peery to the Company's board of directors (the "Board"). Mr. Peery, who also currently serves as the SpeakEasy's President, stated: "I am excited to join the Geen family and the other board members in furthering SpeakEasy's quest in this ever changing and exciting industry". Mr. Peery has been a member of SpeakEasy's Advisory Board since May 2018 and was appointed President of SpeakEasy in July 2018. Prior to that, Mr. Peery was a portfolio manager with Hennessy Funds of San Francisco, where he oversaw in excess of $3 billion in assets. Previously, Mr. Peery held positions as senior equities analyst and managed the research and trading divisions of both full-service and boutique investment firms.
The Company also announces that Anthony Jackson has resigned from the Board and as Chief Financial Officer of the Company. The Company thanks Mr. Jackson for his service the Company and wishes him all the best in his future endeavors.
SpeakEasy has commenced the search for Mr. Jackson's replacement and the Company will take the time necessary to find a suitable candidate. In the interim, Mervyn Geen, a director of the Company, will assume the role of Acting Chief Financial Officer.
In addition, the Company also announces that its private placement (the "Offering"), previously announced on September 4, 2018, has been oversubscribed. The Company now proposes to issue up to 4,428,571 units ("Units") at a price of $0.70 per Unit to raise gross proceeds of up to $3,100,000. Each Unit will consist of one common share in the capital of the Company (a "Common Share") and one-half of a Common Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to acquire an additional Common Share at a price of $1.00 for a period of 24 months from the closing of the Offering.
HEXO acquiert une participation dans une installation de 2 M pi2 à Belleville (Ontario) afin de créer un centre d’excellence pour les coentreprises
GATINEAU, Québec, 10 sept. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO) a annoncé l’acquisition d’une participation dans une installation de 2 004 000 pieds carrés à Belleville, en Ontario. Il s’agit de la première installation de la Société à l’extérieur du Québec, marquant ainsi la poursuite de sa stratégie d’expansion nationale et l’agrandissement de sa capacité de fabrication de produits de cannabis de pointe, y compris, les produits cosmétiques, les vapoteuses, les boissons non alcoolisées et autres produits comestibles.
Située en un lieu central parfaitement positionné sur les grandes voies maritimes de l’Ontario, l’installation offre la possibilité de traiter et de distribuer des produits et de remplir des commandes partout au Canada. L’espace prend également en charge le modèle en étoile préconisé par la Société. Par son évolutivité, sa flexibilité et son emplacement, l’emplacement est idéal pour réaliser les futures coentreprises prévues avec des sociétés du Fortune 500 qui produisent des cosmétiques, des comestibles et plus encore, ce qui en fera un centre d’excellence pour toutes les coentreprises d’HEXO. Cette expansion conduira également à la création d’emplois et à la revitalisation du marché du travail dans la région.
L’immeuble, autrefois l’un des centres de distribution de Sears, sera détenu en coentreprise avec Olegna Holdings Inc. Au départ, HEXO prévoit de louer jusqu’à 500 000 pi2 d’espace auprès de la coentreprise. L’utilisation proposée du bâtiment est assujettie à la condition que les autorités municipales approuvent la demande de rezonage.
« Il existe un bassin de main-d’œuvre qualifiée dans la région de Belleville, et nous avons le vif désir d’y puiser, a déclaré Sébastien St-Louis, cofondateur et PDG d’HEXO. Nous investissons dans la région et sa population afin de nous hisser à une présence nationale durable. Nous nous aventurons pour la première fois hors du Québec avec la volonté de faire la preuve de notre engagement à nous développer à l’échelle nationale pour desservir l’ensemble du pays. Nous gardons également l’œil sur les futures possibilités de partenariat et les débouchés internationaux qui s’offrent à nous. »
L’immeuble appartient à Belleville Complex Inc., une coentreprise dans laquelle HEXO détiendra une participation de 25 % et Olegna Holdings Inc., une participation de 75 %. En plus de louer 500 000 pi2 d’espace en vertu d’un bail à long terme, HEXO aura des droits de première offre et de premier refus relativement à la location de l’espace restant dans l’immeuble. Dans le cadre de la transaction, HEXO a consenti un prêt de 20 000 000 $ à Belleville Complex pour acquérir l’immeuble. Le prêt sera remboursé en 120 jours à compter du 7 septembre 2018. De plus, à compter du 7 octobre 2018, il portera intérêt au taux annuel de 4 %. Ces intérêts seront payables mensuellement. Le prêt est garanti par une première hypothèque sur l’immeuble. La conclusion de la transaction, qui dépend de la satisfaction de certaines conditions, est prévue pour le 12 octobre 2018.
HEXO acquires interest in 2M sq. ft. facility in Belleville, Ontario to create R&D and manufacturing centre of excellence
GATINEAU, Quebec, Sept. 10, 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) has announced the acquisition of an interest in a 2,004,000 sq. ft. facility in Belleville, Ontario. This is the first facility of the Company to be established outside of Quebec, further delivering on its national expansion strategy and providing capacity for the manufacturing of advanced cannabis products, including cosmetics, vapes, non-alcoholic beverages and other edibles.
The centralized location, conveniently located along primary shipping routes in Ontario, presents the opportunity to process and distribute products and to fulfil commitments across Canada. The space also supports the Company’s hub and spoke model. Its scalability, flexibility and location are ideal to deliver on anticipated future joint ventures with Fortune 500 companies for cosmetics, edibles, vapes, and more, positioning it to become a centre of excellence for all of HEXO’s joint ventures. HEXO’s expansion will also lead to the creation of jobs and a rejuvenated employment sector for the area.
The building, previously used as a Sears distribution centre, will be owned in a joint venture with Olegna Holdings Inc. Initially, HEXO plans to lease up to 500,000 sq. ft. of the space from the joint venture. The proposed use of the building is conditional on the city approving the rezoning application.
“There is a skilled workforce in the Belleville area, and we look forward to capturing it,” said Sebastien St-Louis, HEXO’s co-founder and CEO. “We are investing in the region and its people with a view to achieving a sustainable national presence. For the first time, we are stepping out of our home province of Quebec and are committed to and demonstrating our commitment to serve and expand across Canada. And we are keeping future partnership and international opportunities in sight for the near future.”
The building is owned by Belleville Complex Inc., a joint venture in which HEXO will hold a 25% interest and Olegna Holdings Inc. will hold a 75% interest. In addition to its initial lease of 500,000 sq. ft. of the space under a long-term lease, HEXO will have rights of first offer and first refusal to lease the remaining space in the building. As part of the transaction, HEXO has loaned $20,000,000 to Belleville Complex to acquire the building. The loan will be repaid within 120 days from September 7, 2018, and as of October 7, 2018, will bear interest at an annual rate of 4%, which interest shall be payable monthly. The loan is secured by a first mortgage over the building. The transaction is subject to the satisfaction of certain conditions and is scheduled to close on October 12, 2018.
Emerald Health Therapeutics Named as Cannabis Supplier by Newfoundland Labrador Liquor Corporation to Provide Adult-Use Cannabis Products
VICTORIA, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) has been selected as an authorized cannabis supplier by the Newfoundland Labrador Liquor Corporation ("NLC") to supply cannabis products to the NLC and serve the adult-use market throughout the province of Newfoundland Labrador starting October 17.
“We’re proud to work with the NLC as a preferred Licensed Producer to serve Newfoundland and Labrador in the upcoming legal cannabis market,” said Chris Wagner, CEO at Emerald. “This represents the third provincial agreement for our team and we expect to share additional supply updates in the future.”
With its previously announced supply agreements with the provinces of British Columbia and Ontario, as well as its commercial production facilities quickly ramping up in British Columbia and Quebec, Emerald is prepared for the adult-use market. The company is focused on product innovation that will command high profit margins; differentiating its marketing strategy; and securing significant supplies of safe, quality, low-cost cannabis.
About Emerald Health Therapeutics, Inc.
Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC, and is in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.
Transaction Establishes Strong Foundation for Aurora’s South American Growth Strategy in Medical, Adult Consumer Use and CBD Wellness Markets
EDMONTON, Alberta and VANCOUVER, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (Aurora or the Company) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and ICC Labs Inc. (TSX-V: ICC) (ICC) announced today that the companies have entered into a definitive arrangement agreement pursuant to which Aurora intends to acquire all of the issued and outstanding common shares of ICC (the ICC Shares) for $1.95 per share (payable in common shares of Aurora (the Aurora Shares) (the Share Consideration), reflecting an aggregate purchase price of approximately $290 million (the Transaction). The Transaction has been unanimously approved by the Board of Directors of each ICC and Aurora.
Led by CEO Alejandro Antalich, a widely-recognized leader in the South American cannabis market with over 25 years of experience in the pharmaceutical sector, the acquisition of ICC will establish Aurora as the industry leader in South America, a continent with over 420 million people. ICC presently has over 70% market share in Uruguay, the first country in the world to legalize cannabis for adult consumer use. In addition, ICC holds licenses in Colombia for the production of medical cannabis.
The Transaction, once approved, creates a strong foundation for expansion, and will leverage ICC’s first mover advantage in South America, bringing significant low-cost production capacity, a well-diversified product portfolio, and extensive distribution channels throughout South America and internationally.
VANCOUVER, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") is pleased to provide a corporate update in respect of its key milestones in 2018. The Company continues to move forward and execute its business plan of building a vertically integrated global cannabis company. Originally founded with the primary intent of providing financing solutions to licensed producers and licensed producer applicants, the Company has since evolved into a global cannabis company with assets in each key segment of the cannabis value chain.
The Company remains confident in its business strategy as the Canadian market enters legalization of recreational cannabis on October 17, 2018. Auxly’s business is divided into three distinct verticals and management has prioritized the following objectives for each of the Company’s business segments:
Debt and Equity Financings
In order to fund the execution of its business plan, the Company successfully raised in excess of $215,000,000 by way of the two separate financing transactions described below as well as $94,039,000 from the exercise of warrants. The proceeds of the financings and warrant exercises help ensure that Auxly has sufficient capital to fund its business in the short term and gives the Company the flexibility to consider new opportunities as they arise.
Record Clinic Revenue in Q2 Along With Cannabis Sales to Provide Multiple Immediate Income Streams
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“Aleafia“) or (the “Company“), one of Canada’s leading, vertically integrated medical cannabis companies, is announcing that it has secured its first sale of high-quality medical cannabis to CannTrust Holdings Inc. (TSX: TRST) (“CannTrust”), one of Canada’s leading and most trusted licensed producers of cannabis.
The sale follows the company attaining its Sales Licence from Health Canada days earlier.
Aleafia recorded record revenue primarily from clinic operations reported in its second-quarter earnings, and will reach a fully funded growing capacity of 38,000 kg of cannabis flower in early 2019.
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), today announced its intention to purchase approximately $1 million of units (“Units”) of 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic (“Compass”) at a price of $0.60 per Unit. Each Unit will consist of one common share in the capital of Compass (each, a “Compass Share”) and one-half of one common share purchase warrant, with each whole warrant entitling the holder purchase one (1) additional Compass Share at a price of $0.75 per share for a period of twenty-four (24) months, subject to adjustments in certain events.
Compass and its wholly owned subsidiary adult-use retail entity Starbuds Canada have forty confirmed leases for locations across Canada, a mix of operational clinics that are now open, in development, or in preparation with the intended use of becoming retail cannabis stores upon legalization on October 17, 2018. Starbuds Canada – licensee of the Starbuds brand name for Canada from Starbuds based out of Denver, Colorado – has an aggressive expansion plan across Ontario, British Columbia, Alberta and Saskatchewan to serve cannabis enthusiasts across Canada. A wholly-owned subsidiary of Compass, Starbuds Canada has received a cannabis retail license or a conditional license in two provinces along with a dozen retail development permits across the province of Alberta.
“Compass has a highly regarded reputation as a leading provider of cannabis education and patient-centred care. Emblem is committed to supporting Compass’ continued mission to provide the best in patient care now, and upon legalization with a new consumer audience after October 17, 2018.” said Nick Dean, CEO, Emblem Corp. “Building a strong presence in the retail environment will be key to connecting directly with consumers through customer education, product information and building brand affinity. We look forward to working with Compass to provide cannabis consumers with an exceptional retail experience.”
Emblem’s investment in Compass is subject to customary closing conditions and is expected to be completed on or about September 30, 2018.
About Emblem Emblem, through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR. Emblem's state-of-the-art indoor cannabis cultivation facility and research and development laboratory is located in Paris, Ontario. Led by an experienced management team of healthcare executives, accomplished marketing professionals, and cannabis experts, Emblem is focused on driving shareholder value through product innovation, brand relevance, and access to patient and consumer channels. Emblem is also the parent company of GrowWise Health Limited, one of Canada's leading cannabis education services. Emblem trades under the ticker symbol EMC on the TSX Venture Exchange.
TORONTO, Sept. 10, 2018 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF) is pleased to be featured as the Keynote Interview for the upcoming Green Market Summit this Friday, September 14, 2018 with CNBC's Jim Cramer.
Founder of TheStreet.com, American TV personality, former hedge fund manager, and best-selling author Jim Cramer will be interviewing Brian Athaide, TGOD's CEO, on the Company's successful IPO, future growth strategy, the future of cannabis beverages, international markets, and more. Expect Cramer to ask former P&G executive Athaide about his new role as CEO and why he thinks his product will resonate with consumers. This will be the first cannabis conference attended by Jim Cramer.
The Green Market Summit, The Advanced State of Cannabis Economics will take place Friday, September 14, 2018 at the One World Trade Center in New York City. More information on the event is available here.
"I am excited to share our story with CNBC's Jim Cramer this Friday," said Brian Athaide, TGOD's CEO. "With such a vast US shareholder base and our objective to list on the NYSE in the near future, I look forward to the opportunity to showcase our company, methodology, and differentiated approach focused on both organic, beverages, and the international markets to a strong, sophisticated US audience," Continued Athaide.
On Behalf of the Board of Directors,